PARADIGM-extensie

A multicenter study to evaluate safety and tolerability in patients with chronic heart failure and reduced ejection fraction from PARADIGM-HF receiving open label LCZ696

Stadium
klaar
Middel
LCZ696
Populatie
Hartfalen
Fase
extensie
First Patient In
15 februari 2015
Last Patient In
-
Last Patient Last Visit
-

Studiedirecteur

dr. A. Mosterd

Cardioloog

De pagina is verlopen.